MEAD

Welcome to the Brand page for “MEAD”, which is offered here for Dietary and nutritional supplements; dietary and nutritional supplements used for dialysis; dietary and nutritional supplements for treating cancer; dietary and nutritional supplements for use in connection with a variety of therapeutic areas; dietary and nutritional supplements designed to remediate nutrient deprivation; dietary and nutritional supplements designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases; dietary and nutritional supplements for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics;dietary and nutritional supplement research services; dietary and nutritional supplement research and development; research and development in dietary and nutritional supplements for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; dietary and nutritional supplement research in the field of dialysis; dietary and nutritional supplement research in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials; dietary and nutritional supplement research, research relating to remediating nutrient deprivation for use in connection with a wide variety of therapeutic areas;.

Its status is currently believed to be active. Its class is unavailable. “MEAD” is believed to be currently owned by “Filtricine, Inc.”